CytoDyn to Present at Wall Street Reporter’s NEX
Post# of 148187
Download as PDFMarch 18, 2020 3:52pm EDT
VANCOUVER, Washington, March 18, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company" , a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Nader Pourhassan, Ph.D., president and chief executive officer, will present an update on recent developments, as well as an overview of upcoming milestones anticipated in 2020 for multiple potential therapeutic indications for leronlimab at Wall Street Reporter’s NEXT SUPER STOCK – live stream event on Thursday, March 19, 2020 at 12:30 p.m. ET / 9:30 a.m. PT.
Date: Thursday, March 19, 2020
Time: 12:30 p.m. ET / 9:30 a.m. PT
Access: https://register.gotowebinar.com/register/187...6306369292
The livestream presentation will be archived for 30 days and participants are encouraged to go to the above-referenced website 10 minutes prior to the start of the presentation. For anyone unable to attend, a video will be posted on CytoDyn’s website approximately 24 hours after the presentation. The conference sponsor provides corporate visibility services to CytoDyn for a fee.